The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
mTOR is a key modulator of ageing and age-related disease
Open accessAbstract
Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the mammalian target of rapamycin (mTOR) pathway, which is induced by amino acids, growth factors, and RT, is often inhibited during CR, and mediates CR-induced health benefits in model organisms [37].”
From Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a well-known inhibitor of mTOR, rapamycin, inhibits the production of SASP factors”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which might explain its beneficial impact on longevity [121,122].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic down-regulation of mTORC1 activity in yeast, worms and flies extends longevity and attenuates further longevity benefits from DR, suggesting that mTOR inhibition phenocopies DR”
From The Hallmarks of Aging (2013) · cites this paper as Johnson et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inhibition of mTOR has been shown to extend lifespan and to improve the function of ageing organ systems, including the immune system, in multiple preclinical species.18, 19”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“One of the best validated mechanisms underlying ageing biology is the activity of the protein kinase mTOR.”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“More importantly, these pathways have been evaluated in mammalian models, in which health span and lifespan have been extended by genetic manipulation or drugs (Johnson et al., 2013).”
From Metformin as a tool to target aging (2016) · cites this paper as Johnson et al., 2013
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Based on previous studies in the aging field, it is believed that Nrf2 is repressed by mTOR pathway (downstream target); therefore, an inhibition of mTOR by rapamycin would increase the activity of Nrf2 (Johnson et al., 2013).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Johnson et al., 2013
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Aging, natural death, and the compression of morbidity
Fries, J. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030304 · Cited by 3,356
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,006
Marzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 126
Regulation of longevity by FGF21: interaction between energy metabolism and stress responses
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.004 · Cited by 121
Cancer—Incidence, prevalence and mortality in the oldest-old. A comprehensive review
Nolen, S. C., Evans, M. A., Fischer, A., Corrada, M. M., Kawas, C. H., & Bota, D. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.05.002 · Cited by 126
Mouse aging cell atlas analysis reveals global and cell type-specific aging signatures
Zhang, M. J., Pisco, A. O., Darmanis, S., & Zou, J. (2021) · eLife · doi:10.7554/elife.62293 · Cited by 121
Feng, X., Pan, J., Li, J., Zeng, C., Qi, W., Shao, Y. X., Liu, X., Liu, L., Xiao, G., Zhang, H., et al. (2020) · Aging · doi:10.18632/aging.102635 · Cited by 124
“At the same time, phosphorylation of AMPK blocks the phosphorylation of the mTOR signaling pathway and inhibits its corresponding biological function [30, 48], ultimately regulating the progression of OA.”
BackgroundThe Effects of Calorie Restriction on Autophagy: Role on Aging Intervention
Chung, K. W., & Chung, H. Y. (2019) · Nutrients · doi:10.3390/nu11122923 · Cited by 125
“Since increased mTOR activity has been reported in various age-related diseases including metabolic and degenerative disorders, it is plausible that increased mTOR signaling is the predominant cause for the downregulation of the overall autophagy process [46].”
BackgroundOsteoporosis remission via an anti-inflammaging effect by icariin activated autophagy
Bai, L., Liu, Y., Zhang, X., Chen, P., Hang, R., Xiao, Y., Wang, J., & Liu, C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122125 · Cited by 124
Metformin: Do we finally have an anti-aging drug?
Anisimov, V. N. (2013) · Cell Cycle · doi:10.4161/cc.26928 · Cited by 125
Antignano, I., Liu, Y., Offermann, N., & Capasso, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04775-y · Cited by 117
“mTOR is a critical node that regulates cell growth and metabolism in all cell types and its inhibition is linked to increased longevity [53].”
BackgroundWei, Y.-N., Hu, H.-Y., Xie, G.-C., Fu, N., Ning, Z.-B., Zeng, R., & Khaitovich, P. (2015) · Genome Biology · doi:10.1186/s13059-015-0608-2 · Cited by 117
Caenorhabditis elegans: a model to understand host–microbe interactions
Kumar, A., Baruah, A., Tomioka, M., Iino, Y., Kalita, M. C., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03319-7 · Cited by 126
COVID-19, Virology and Geroscience: A Perspective
Vellas, C., Delobel, P., Barreto, P. D. S., & Izopet, J. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1416-2 · Cited by 120
Blagosklonny, M. V. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.506 · Cited by 115
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012518 · Cited by 115
Periodontitis and Accelerated Biological Aging: A Geroscience Approach
Baima, G., Romandini, M., Citterio, F., Romano, F., & Aimetti, M. (2021) · Journal of Dental Research · doi:10.1177/00220345211037977 · Cited by 123
Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease
Pryor, W. M., Biagioli, M., Shahani, N., Swarnkar, S., Huang, W., Page, D. T., MacDonald, M. E., & Subramaniam, S. (2014) · Science Signaling · doi:10.1126/scisignal.2005633 · Cited by 111
The role of epigenetics in renal ageing
Shiels, P. G., McGuinness, D., Eriksson, M., Kooman, J. P., & Stenvinkel, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.78 · Cited by 114
4-hydroxynonenal-mediated signaling and aging
Zhang, H., & Forman, H. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.032 · Cited by 114
Nutrients in the Prevention of Alzheimer’s Disease
Cremonini, A. L., Caffa, I., Cea, M., Nencioni, A., Odetti, P. R., & Monacelli, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9874159 · Cited by 121
“During protein restriction, mTOR, and in particular complex 1 (mTORC1), is repressed, thus allowing the cell to enter a “conservative” energy mode to inhibit protein and lipid synthesis and enhanced autophagy [179, 180].”
BackgroundReversal of phenotypes of cellular senescence by pan-mTOR inhibition
Walters, H. E., Deneka-Hannemann, S., & Cox, L. S. (2016) · Aging · doi:10.18632/aging.100872 · Cited by 113
Myelin lipid metabolism and its role in myelination and myelin maintenance
Barnes-Vélez, J. A., Aksoy Yasar, F. B., & Hu, J. (2023) · The Innovation · doi:10.1016/j.xinn.2022.100360 · Cited by 73
Molecular insights into the premature aging disease progeria
Vidak, S., & Foisner, R. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1411-1 · Cited by 115
Biochemical Basis of Sestrin Physiological Activities
Ho, A., Cho, C., Namkoong, S., Cho, U., & Lee, J. H. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.04.005 · Cited by 115
Lysosomal Signaling Promotes Longevity by Adjusting Mitochondrial Activity
Ramachandran, P. V., Savini, M., Folick, A., Hu, K. Y., Masand, R., Graham, B. H., & Wang, M. C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.022 · Cited by 112
“, 2013), and both mTORC1 and TFEB have been implicated in the regulation of longevity (Johnson et al., 2013; Kennedy and Lamming, 2016; Lapierre et al., 2013).”
Effects of anti-aging interventions on intestinal microbiota
Du, Y., Gao, Y., Zeng, B., Fan, X., Yang, D., & Yang, M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1994835 · Cited by 118
“Reducing mTOR expression can prolong model animals’ lifespan and healthspan.(5) However, the inability to control gene change hinders its application in human society.”
BackgroundA metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment
Xu, Z., Wu, Z., Huang, S., Ye, K., Jiang, Y., Liu, J., Liu, J., Lu, X., & Li, B. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.024 · Cited by 114
Martínez-Cisuelo, V., Gómez, J., García-Junceda, I., Naudí, A., Cabré, R., Mota‐Martorell, N., Lopez‐Torres, M., González-Sánchez, M., Pamplona, R., & Barja, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.08.002 · Cited by 111
Protein Turnover in Aging and Longevity
Basisty, N., Meyer, J. G., & Schilling, B. (2018) · PROTEOMICS · doi:10.1002/pmic.201700108 · Cited by 111
Longevity extension in Drosophila through gut-brain communication
Westfall, S., Lomis, N., & Prakash, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25382-z · Cited by 113
Hoong, C. W. S., & Chua, M. W. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab079 · Cited by 112
Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation
Melnik, B. C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817048 · Cited by 108
Wang, T., Babayev, E., Jiang, Z., Li, G., Zhang, M., Esencan, E., Horváth, T. L., & Seli, E. U. (2018) · Aging Cell · doi:10.1111/acel.12784 · Cited by 106
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Inflammation Research · doi:10.1007/s00011-021-01498-3 · Cited by 115
Iakovou, E., & Kourti, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.827900 · Cited by 119
“Several experimental studies have shown that the administration of mTOR inhibitors to mice extended life expectancy by 9%–14%, even when the administration started relatively late (Harrison et al., 2009; Anisimov et al., 2011; Miller et al., 2011; Johnson et al., 2013).”
BackgroundmTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Marafie, S. K., Al‐Mulla, F., & Abubaker, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116141 · Cited by 119
“The role of mTOR signaling with regard to aging has been highlighted in different studies and is shown to be conserved from yeast to mammals [23,60].”
BackgroundhNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling
Wang, X., Chrysovergis, K., Kosak, J., Kissling, G., Streicker, M., Moser, G., Li, R., & Eling, T. E. (2014) · Aging · doi:10.18632/aging.100687 · Cited by 106
Cause or casualty: The role of mitochondrial DNA in aging and age-associated disease
Chocrón, E. S., Munkácsy, E., & Pickering, A. M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.035 · Cited by 117
“It is worth noting that lifespan extending interventions such as caloric restriction and mTOR inhibition both lead to increased autophagy and mitophagy [55].”
BackgroundThe Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation
Bjedov, I., & Rallis, C. (2020) · Genes · doi:10.3390/genes11091043 · Cited by 108
“The complexity and breadth of connections of mTOR signalling pathway with other nutrient- and growth factor-responsive pathways imposes great toxicity risks when using high doses of inhibitors [5,185] and optimal dosages and durations of treatment are unknown factors [186].”
BackgroundPan, R.-Y., Zhang, J., Wang, J., Wang, Y., Li, Z., Liao, Y., Liao, Y., Zhang, C., Liu, Z., Song, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00311-y · Cited by 107
Antiaging agents: safe interventions to slow aging and healthy life span extension
Liu, J. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 112
“In model organisms such as fruit flies and worms, mutation of mTORC1 signaling pathway components or activation of upstream inhibitors prolongs lifespan [295].”
BackgroundRejuvenating Aged Bone Repair through Multihierarchy Reactive Oxygen Species‐Regulated Hydrogel
He, Z., Sun, C., Ma, Y., Chen, X., Wang, Y., Chen, K., Xie, F., Zhang, Y., Yuan, Y., & Liu, C. (2023) · Advanced Materials · doi:10.1002/adma.202306552 · Cited by 109
Caloric restriction and cellular senescence
Fontana, L., Nehme, J., & Demaria, M. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.10.005 · Cited by 104
Nucleophagy: from homeostasis to disease
Papandreou, M., & Tavernarakis, N. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0266-5 · Cited by 107
Longevity: Lesson from Model Organisms
Taormina, G., Ferrante, F., Vieni, S., Grassi, N., Russo, A. G., & Mirisola, M. G. (2019) · Genes · doi:10.3390/genes10070518 · Cited by 112
“Among these, Obp99b seems to have a key role, since it is upregulated in a long-lived Drosophila model [63]. mTOR inhibition also by rapamycin administration [64] extends life spans [65], but only in the presence of the s6 kinase [65,66].”
BackgroundAlqawlaq, S., Flanagan, J. G., & Sivak, J. M. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.11.005 · Cited by 107
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Xu, J., Zhou, L., & Liu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601325 · Cited by 113
“Of interest, rapamycin prolongs lifespan in multiple animal models (Kapahi et al., 2004; Johnson et al., 2013; Weichhart, 2018).”
BackgroundTurgeon, N., Blais, M., Gagné, J. M., Tardif, V., Boudreau, F., Perreault, N., & Asselin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073785 · Cited by 105
Goldberg, E. L., Romero-Aleshire, M. J., Renkema, K. R., Ventevogel, M. S., Chew, W. M., Uhrlaub, J. L., Smithey, M. J., Limesand, K. H., Sempowski, G. D., Brooks, H. L., et al. (2014) · Aging Cell · doi:10.1111/acel.12280 · Cited by 107
Nutrient Sensing and the Oxidative Stress Response
Luo, H., Chiang, H.-H., Louw, M., Susanto, A., & Chen, D. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.008 · Cited by 107
Mazucanti, C. H., Cabral‐Costa, J. V., Vasconcelos, A. R., Andreotti, D. Z., Scavone, C., & Kawamoto, E. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 103
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease
Johnson, S. C. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_3 · Cited by 104
Exploring the Impact of Obesity on Skeletal Muscle Function in Older Age
Morgan, P. T., Smeuninx, B., & Breen, L. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.569904 · Cited by 108
Transcriptional regulation of the stress response by mTOR
Aramburu, J. F., Ortells, M. C., Vaquero, S. T., Buxadé, M., & López‐Rodríguez, C. (2014) · Science Signaling · doi:10.1126/scisignal.2005326 · Cited by 100
Müller, L. P. D. S., Sargoy, A., Rodriguez, A. R., & Brecha, N. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093274 · Cited by 96
He, C. Z., Tsuchiyama, S. K., Nguyen, Q. T. T., Proshkina, E., Terrill, S. R., Sahibzada, S., Patel, B., Faulkner, A. R., Shaposhnikov, M. V., Tian, R., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004860 · Cited by 97
Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
Xu, J., Pham, C. G., Albanese, S. K., Dong, Y., Oyama, T., Lee, C., Rodrik-Outmezguine, V. S., Yao, Z., Han, S. I., Chen, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86120 · Cited by 100
Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.08.009 · Cited by 100
“The mTORC1 complex has a fundamental role in the regulation of the aging process and agerelated diseases [139,141].”
BackgroundOlive Oil and the Hallmarks of Aging
Fernández-del-Río, L., Gutiérrez-Casado, E., Varela‐López, A., & Villalba, J. M. (2016) · Molecules · doi:10.3390/molecules21020163 · Cited by 100
Rapamycin rejuvenates oral health in aging mice
An, J. Y., Kerns, K. A., Ouellette, A. R., Robinson, L., Morris, D., Kaczorowski, C. C., Park, S.-I., Mekvanich, T., Kang, A., McLean, J. S., et al. (2020) · eLife · doi:10.7554/elife.54318 · Cited by 100
“Rapamycin, an FDA-approved drug, which directly inhibits the mechanistic target of rapamycin complex I (mTORC1), is one such intervention that extends lifespan and ameliorates a variety of agerelated phenotypes (Johnson et al., 2013).”
BackgroundIntestinal barrier dysfunction: an evolutionarily conserved hallmark of aging
Salazar, A. M., Aparício, R., Clark, R. I., Rera, M., & Walker, D. W. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049969 · Cited by 98
“…can prolong lifespan in model organisms, including flies and mice (Bjedov et al., 2010; Dai et al., 2014; Flynn et al., 2013; Harrison et al., 2009; Johnson et al., 2013; Kennedy and Lamming, 2016; Majumder et al., 2012; Schinaman et al., 2019; Spilman et al., 2010; Wilkinson et al., 2012).”
A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Mahoney, S. J., Narayan, S., Molz, L., Berstler, L. A., Kang, S. A., Vlasuk, G. P., & Saiah, E. (2018) · Nature Communications · doi:10.1038/s41467-018-03035-z · Cited by 88
Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila
Schinaman, J. M., Rana, A., Ja, W. W., Clark, R. I., & Walker, D. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-44106-5 · Cited by 99
Modulating mTOR in Aging and Health
Johnson, S. C., Sangesland, M., Kaeberlein, M. R., & Rabinovitch, P. S. (2014) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000364974 · Cited by 92
Moving geroscience from the bench to clinical care and health policy
Sierra, F., Caspi, A., Fortinsky, R. H., Haynes, L., Lithgow, G. J., Moffitt, T. E., Olshansky, S. J., Perry, D., Verdin, E., & Kuchel, G. A. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17301 · Cited by 92
“First among these were studies conducted using simple animal models and then mice, demonstrating that targeting pathways such as mTOR (mammalian target of rapamycin) signaling with drugs or drug-like molecules could also extend lifespan(7) and healthspan.(8) Studies soon followed showing an impact on lifespan and heal…”
BackgroundAltman, J. K., Szilard, A., Goussetis, D. J., Sassano, A., Colamonici, M., Gounaris, E. G., Frankfurt, O., Giles, F. J., Eklund, E. A., Beauchamp, E. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3218 · Cited by 95
Nutritional regulation of stem and progenitor cells in Drosophila
Shim, J., Rao, S. G., & Banerjee, U. K. (2013) · Development · doi:10.1242/dev.079087 · Cited by 93
Regan, J. C., Froy, H., Walling, C. A., Moatt, J. P., & Nussey, D. H. (2019) · Functional Ecology · doi:10.1111/1365-2435.13418 · Cited by 97
Zhang, Y., Zhang, W.-H., Zhang, P., Li, Q., Sun, Y., Wang, J., Zhang, S. O., Cai, T., Zhan, C., & Dong, M. (2022) · Nature Communications · doi:10.1038/s41467-022-33850-4 · Cited by 99
m TORC 2‐ SGK ‐1 acts in two environmentally responsive pathways with opposing effects on longevity
Mizunuma, M., Neumann‐Haefelin, E., Moroz, N., Li, Y., & Blackwell, T. K. (2014) · Aging Cell · doi:10.1111/acel.12248 · Cited by 92
Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis
Li, J., Ren, J., Liu, X., Jiang, L., He, W., Yuan, W., Yang, J., & Dai, C. (2015) · Kidney International · doi:10.1038/ki.2015.119 · Cited by 95
Aging‐related Atg5 defect impairs neutrophil extracellular traps formation
Xu, F., Zhang, C., Zou, Z., Fan, E., Chen, L., Li, Y., Billiar, T. R., Wilson, M. A., Shi, X., & Fan, J. (2017) · Immunology · doi:10.1111/imm.12740 · Cited by 98
The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging
Zhang, Y., Zhang, J., & Wang, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101376 · Cited by 92
Pan-mammalian analysis of molecular constraints underlying extended lifespan
Kowalczyk, A., Partha, R., Clark, N. L., & Chikina, M. (2020) · eLife · doi:10.7554/elife.51089 · Cited by 95
“Perturbations of IGF1 signaling result in changes in lifespan and body size in diverse organisms (Johnson et al., 2013; Kimura et al., 1997; Stout et al., 2013), which suggests that the IGF1 G1 M”
BackgroundRapamycin, Autophagy, and Alzheimer's Disease.
Cai, Z., & Yan, L. (2013) · PubMed · Cited by 97
Histone Modifications as an Intersection Between Diet and Longevity
Molina‐Serrano, D., Kyriakou, D., & Kirmizis, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00192 · Cited by 94
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice
Johnson, S. C., Yanos, M. E., Bitto, A., Castanza, A. S., Gagnidze, A., González, B., Gupta, K., Hui, J., Jarvie, C., Johnson, B. M., et al. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00247 · Cited by 93
Independent and Additive Effects of Glutamic Acid and Methionine on Yeast Longevity
Wu, Z., Song, L., Liu, S., & Huang, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079319 · Cited by 89
Yang, J., Zhou, X., Fan, X., Xiao, M., Yang, D., Liang, B., Dai, M., Shan, L., Lu, J., Lin, Z., et al. (2016) · Blood · doi:10.1182/blood-2015-10-672964 · Cited by 93
MEK drives cyclin D1 hyperelevation during geroconversion
Leontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.86 · Cited by 91
Dietary restriction involves NAD +‐dependent mechanisms and a shift toward oxidative metabolism
Moroz, N., Carmona, J. J., Anderson, E. N., Hart, A. C., Sinclair, D. A., & Blackwell, T. K. (2014) · Aging Cell · doi:10.1111/acel.12273 · Cited by 88
The role of hydrogen sulfide in aging and age-related pathologies
Perridon, B. W., Leuvenink, H. G. D., Hillebrands, J., van Goor, H., & Bos, E. M. (2016) · Aging · doi:10.18632/aging.101026 · Cited by 90
Dai, C., Ciccotosto, G. D., Cappai, R., Wang, Y., Tang, S., Hoyer, D., Schneider‐Futschik, E. K., Velkov, T., & Xiao, X. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00323 · Cited by 89
Tuberous sclerosis complex–mediated mTORC1 overactivation promotes age-related hearing loss
Fu, X., Sun, X., Zhang, L., Jin, Y., Chai, R., Yang, L., Zhang, A., Liu, X., Bai, X., Li, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98058 · Cited by 92
Li, Q., Xie, J., Li, R., Shi, J., Sun, J., Gu, R., Ding, L., Wang, L. Y., & Xu, B. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12242 · Cited by 89
Insulin and TOR signal in parallel through FOXO and S6K to promote epithelial wound healing
Kakanj, P., Moussian, B., Grönke, S., Bustos, V., Eming, S. A., Partridge, L., & Leptin, M. (2016) · Nature Communications · doi:10.1038/ncomms12972 · Cited by 87
Interventions on Gut Microbiota for Healthy Aging
Zeppa, S. D., Agostini, D., Ferrini, F., Gervasi, M., Barbieri, E., Bartolacci, A., Piccoli, G., Saltarelli, R., Sestili, P., & Stocchi, V. (2022) · Cells · doi:10.3390/cells12010034 · Cited by 98
“The mTOR kinase pathway detects high concentrations of amino acids [65].”
BackgroundLocatelli, F., Lucarelli, B., & Merli, P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.852537 · Cited by 91
Towards a unified mechanistic theory of aging
Barja, G. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.05.016 · Cited by 90
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 98
“The upregulation of mTOR signaling-dependent translation and heightened protein levels of inflammatory mediators serve as a key driver in the microglia priming in aging and neurodegenerative conditions [8, 256, 257].”
Nutrition and longevity—From mechanisms to uncertainties
Ekmekcioglu, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1676698 · Cited by 87
Hesp, K., Smant, G., & Kammenga, J. E. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.09.006 · Cited by 91
Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues
Liu, H., Xia, X., & Li, B. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215591828 · Cited by 91
Pharmacological Strategies to Retard Cardiovascular Aging
Alfaras, I., Germanio, C. D., Bernier, M., Csiszár, A., Ungvari, Z. I., Lakatta, E. G., & de Cabo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307475 · Cited by 87
Dang, W., Sutphin, G. L., Dorsey, J. A., Otte, G. L., Cao, K., Perry, R. M., Wanat, J. J., Saviolaki, D., Murakami, C. J., Tsuchiyama, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.004 · Cited by 83
mTOR-dependent translation amplifies microglia priming in aging mice
Keane, L., Antignano, I., Riechers, S., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F. J., McCormick, P. N., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132727 · Cited by 93
“The best-known effect mediated by rapamycin is lifespan extension in lower organisms and mammals, mostly attributed to mTOR’s function as a nutrient sensor (84, 85).”
Aging and brain rejuvenation as systemic events
Bouchard, J. J., & Villeda, S. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12969 · Cited by 90
Drug repurposing for the treatment of glioblastoma multiforme
Abbruzzese, C., Matteoni, S., Signore, M., Cardone, L., Nath, K., Glickson, J. D., & Paggi, M. G. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0642-x · Cited by 87
“cellular ageing, [61, 62] and are also employed in Phase 2 clinical trials involving GBM patients showing therapeutic benefits in subjects whose tumor displays high mTORC1 activity [63].”
BackgroundmTORC1 signaling activates NRF1 to increase cellular proteasome levels
Zhang, Y., & Manning, B. D. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1044188 · Cited by 85
Wang, Y., Fu, Z., Li, X., Liang, Y., Pei, S., Hao, S., Zhu, Q., Yu, T., Pei, Y., Yuan, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.02.003 · Cited by 84
Lin, X., Li, S., Wang, Y., Wang, Y., Zhong, J., He, J., Cui, X., Zhan, J., & Liu, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116582 · Cited by 90
Metadata
- Authors
- Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M.
- Affiliations
- University of Washington (US)
- Guangdong Medical College (CN)
- Corresponding author
- Kaeberlein, Matt
- Venue
- Nature
- Published
- 2013-01-16
- Volume
- 493
- Issue
- 7432
- Pages
- 338-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3687363
- OpenAlex
- W2010583480
- Cited by
- 1,676
- References
- 100
- Citations by year
- 2026: 87 · 2025: 82 · 2024: 117 · 2023: 121 · 2022: 113 · 2021: 164 · 2020: 136 · 2019: 140 · 2018: 125 · 2017: 133 · 2016: 136 · 2015: 119 · 2014: 131 · 2013: 72
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031108, T32AG000057, P01AG001751, R01AG039390, R01AG038550, P30AG013280)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mTOR, aging, age-related diseases, lifespan extension, rapamycin, mTOR inhibitors, pharmacological interventions
- MeSH terms
- Aging, Animals, Humans, Insulin, Insulin-Like Growth Factor I, Longevity, Signal Transduction, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
